Knowledge Center
Article / Sep 23, 2014
Quality Metrics - A Case for an FDA Dean's List
Source:
Pharmaceutical Technology, September 2014
The author (Guy Villax) presents arguments for an FDA Dean's List as a means to drive the right behaviors in the industry.
FDA is moving in the right direction when it looks to rank quality across pharmaceutical manufacturing sites. However quality is a matter of culture rather than metrics or compliance.
- Read the extended version with links to references, examples and case studies here
- Read the article in Pharmaceutical Technology here
Also in the Knowledge Center
/ Aug 03, 2023
Nasal-PAMPA: A novel non-cell-based high throughput screening assay for prediction of nasal drug permeability
Read more
Scientific Article
/ Apr 28, 2023
Capsule filling for DPIs: Linking Process scales through advanced characterisation and Quality by Design
Read more
Scientific Article
/ Mar 09, 2022
Monofluoromethylation of complex pharmaceutical steroids using non-depleting reagents
Read more
Scientific Article